References
- Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener Granulomatosis: an analysis of 158 patients. Ann In-tern Med 1992; 116: 488–98.
- Chakravarty K. Mortality in systemic vasculitis. Rheumatol Eur 1996; 25: 20–2.
- Orlowski JP, Clough JD, Dyment PG. Wegener's gran-ulomatosis in pediatric age group. Pediatrics 1978; 61: 83–90.
- Neumann G, Benz-Bohm G, Rister M. Wegener's granulomatosis in childhood. Pediatric Radiol 1984; 14: 267–71.
- Hall SL, Miller LC, Duggan E, et al. Wegener granulo-matosis in pediatric patients. J Pediatr 1985; 106: 739–44.
- McHugh K, Manson D, Eberhard BA, Shore A, Laxer RM. Wegener's granulomatosis in childhood. Pediatric Radiol 1991; 21: 552–5.
- Rottem M, Fauci AS, Hallahan CW, et al. Wegener granulomatosis in children and adolescents: Clinical presentation and outcome. J Pediatr 1993; 122: 26–31.
- Verschuur HP, Struyvenberg PAA, van Benthem PPG, et al. Nasal discharge and obstruction as presenting symptoms of Wegener's granulomatosis in childhood. Int J Pediatr Otorhinolaryngol 1993; 27: 91–5.
- McCaffrey T, McDonald TJ, Fsacer GW, deRemee RA. Otologic manifestations of Wegener's granulomatosis. Otolaryngol Head Neck Surg 1980; 88: 586–93.
- Hartl DM, Aidan P, Brugiere 0, Sterkers 0. Wegener's granulomatosis presenting as a recurrence of chronic otitis media. Am J Otolaryngol 1998; 19: 54–60.
- Deccer PJ. Wegener's granulomatosis: otological as-pects. J Otolaryngol 1993; 22: 364–7.
- Dagum P, Roberson JB. Otologic Wegener's granulo-matosis with facial nerve palsy. Ann Otol Rhinol Laryngol 1998; 107: 555–9.
- Rao JK, Weinberger M, Oddone EZ, et al. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener's granulomatosis. Ann Intern Med 1995; 123: 925–32.
- Haubitz M, Schellong S, Gobel U, et al. Intra-venous pulse administration of cyclophosphamide versus daily oral treatment in patients with an-tineutrophil cytoplasmic antibody-associated vasculitis and renal involvement. Arthritis Rheum 1998; 41: 1835–44.
- Stegeman CA, Tervaert JVVC, de Jong PE, Kallenberg CGM, the Dutch co-trimoxazole Wegener study group. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomato-sis. N Engl J Med 1996; 335: 16–20.